NCT05506319View on ClinicalTrials.gov

Hypotension in the Weaning From Vasopressor Drugs

PHASE4CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

December 1, 2022

Study Completion Date

June 30, 2023

Conditions
Septic Shock
Interventions
OTHER

Norepinephrine

The patients will be randomized for the initial suspension of norepinephrine (norepinephrine group).

OTHER

Vasopressin

The patients will be randomized for the initial suspension of vasopressin (vasopressin group).

Trial Locations (1)

91350-200

Hospital Nossa Senhora da Conceicao, Porto Alegre

All Listed Sponsors
lead

Hospital Nossa Senhora da Conceicao

OTHER